Page last updated: 2024-09-03

cholestyramine resin and Metabolic Diseases

cholestyramine resin has been researched along with Metabolic Diseases in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Scheen, AJ1
Gylling, H; Miettinen, TA; Parto, K1
Morrissey, KP1
Edwards, IR; Frenk, E; Walker, AE1
Dietschy, JM; Schiff, ER1
Fromm, H; Hofmann, AF; Smith, LH1

Reviews

3 review(s) available for cholestyramine resin and Metabolic Diseases

ArticleYear
Current concepts of gallstone formation.
    Major problems in clinical surgery, 1975, Volume: 16

    Topics: Animals; Bile; Bile Acids and Salts; Cholecystectomy; Cholelithiasis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet; Gallbladder; Hormones; Humans; Metabolic Diseases; Nicotinic Acids; Phenobarbital; Phosphatidylcholines; Phospholipids; Thyroxine

1975
Therapeutics XIX. Lipid lowering agents.
    The British journal of dermatology, 1972, Volume: 87, Issue:2

    Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins; Metabolic Diseases; Nicotinic Acids; Triglycerides; Xanthomatosis

1972
Steatorrhea associated with disordered bile acid metabolism. Micellar phase defects.
    The American journal of digestive diseases, 1969, Volume: 14, Issue:6

    Topics: Bacteroides; Bile Acids and Salts; Biliary Tract Diseases; Blind Loop Syndrome; Celiac Disease; Cholestyramine Resin; Diagnosis, Differential; Digestion; Escherichia coli; Fatty Acids; Humans; Ileum; Intestinal Diseases; Intestinal Obstruction; Intrinsic Factor; Lipid Metabolism; Liver Circulation; Malabsorption Syndromes; Metabolic Diseases; Triglycerides; Vitamin B 12

1969

Other Studies

3 other study(ies) available for cholestyramine resin and Metabolic Diseases

ArticleYear
[Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine].
    Revue medicale de Liege, 1998, Volume: 53, Issue:11

    Topics: Acarbose; Anion Exchange Resins; Anti-Obesity Agents; Cholestyramine Resin; Diabetes Mellitus; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypercholesterolemia; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Intestine, Small; Lactones; Lipase; Metabolic Diseases; Orlistat; Trisaccharides

1998
[First Finnish phytosterolemia families have been identified].
    Duodecim; laaketieteellinen aikakauskirja, 1999, Volume: 115, Issue:12

    Topics: Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Finland; Humans; Male; Metabolic Diseases; Pedigree; Phytosterols

1999
Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome.
    The New England journal of medicine, 1972, Jun-29, Volume: 286, Issue:26

    Topics: Adult; Aged; Bile Acids and Salts; Cholestyramine Resin; Female; Humans; Ileum; Intestinal Diseases; Kidney Calculi; Male; Metabolic Diseases; Middle Aged; Oxalates; Urography

1972